A deletion and point mutation study of the human papillomavirus type 16 major capsid gene

dc.contributor.authorVarsani, Arvind
dc.contributor.authorWilliamson, Anna-Lise
dc.contributor.authorJaffer, Mohamed A
dc.contributor.authorRybicki, Edward P
dc.date.accessioned2017-10-23T07:22:15Z
dc.date.available2017-10-23T07:22:15Z
dc.date.issued2006
dc.date.updated2017-09-07T10:32:16Z
dc.description.abstractRecombinant human papillomavirus (HPV) virus-like particles (VLPs) made from the major capsid protein L1 are promising vaccine candidates for use as vaccines against genital and other HPV infections, and particularly against HPV-16. However, HPV-16 genotype variants have different binding affinities for neutralising mouse Mabs raised against HPV-16 L1 VLPs. This paper analyses, using a panel of well-characterised Mabs, the effects on the antigenicity of various C- and N-terminal deletants of HPV-16 L1 made in insect cells via recombinant baculovirus, of an A→T mutation at residue 266 (A266T), and of a C→G mutation at conserved position 428 (C428G). The effects of these changes on assembly of the variant L1s were studied by electron microscopy. Binding of Mab H16:E70 to A266T was reduced by almost half in comparison to wild type L1. Retention of the C-terminal region 428–483 was critical for the binding of conformation-specific Mabs (H16:V5, H16:E70, H16:U4 and H16:9A) whereas deletion of the nuclear localisation signal (NLS) or the C428G mutation or an N-terminal deletion (residues 2–9) did not affect the antigenicity. The N-terminal deletion resulted in a mixed population of 30 and 55 nm VLPs, which differs from the same construct expressed in Escherichia coli, whereas pentamer aggregates resulted from deletion of the 428–465 region or the C428G mutation. The results have implications both for considering use of single-genotype HPV vaccines, and for design of novel second-generation vaccines.
dc.identifierhttp://dx.doi.org/10.1016/j.virusres.2006.07.012
dc.identifier.apacitationVarsani, A., Williamson, A., Jaffer, M. A., & Rybicki, E. P. (2006). A deletion and point mutation study of the human papillomavirus type 16 major capsid gene. <i>Virus Research</i>, http://hdl.handle.net/11427/25729en_ZA
dc.identifier.chicagocitationVarsani, Arvind, Anna-Lise Williamson, Mohamed A Jaffer, and Edward P Rybicki "A deletion and point mutation study of the human papillomavirus type 16 major capsid gene." <i>Virus Research</i> (2006) http://hdl.handle.net/11427/25729en_ZA
dc.identifier.citationVarsani, A., Williamson, A. L., Jaffer, M. A., & Rybicki, E. P. (2006). A deletion and point mutation study of the human papillomavirus type 16 major capsid gene. Virus research, 122(1), 154-163.
dc.identifier.ris TY - Journal Article AU - Varsani, Arvind AU - Williamson, Anna-Lise AU - Jaffer, Mohamed A AU - Rybicki, Edward P AB - Recombinant human papillomavirus (HPV) virus-like particles (VLPs) made from the major capsid protein L1 are promising vaccine candidates for use as vaccines against genital and other HPV infections, and particularly against HPV-16. However, HPV-16 genotype variants have different binding affinities for neutralising mouse Mabs raised against HPV-16 L1 VLPs. This paper analyses, using a panel of well-characterised Mabs, the effects on the antigenicity of various C- and N-terminal deletants of HPV-16 L1 made in insect cells via recombinant baculovirus, of an A→T mutation at residue 266 (A266T), and of a C→G mutation at conserved position 428 (C428G). The effects of these changes on assembly of the variant L1s were studied by electron microscopy. Binding of Mab H16:E70 to A266T was reduced by almost half in comparison to wild type L1. Retention of the C-terminal region 428–483 was critical for the binding of conformation-specific Mabs (H16:V5, H16:E70, H16:U4 and H16:9A) whereas deletion of the nuclear localisation signal (NLS) or the C428G mutation or an N-terminal deletion (residues 2–9) did not affect the antigenicity. The N-terminal deletion resulted in a mixed population of 30 and 55 nm VLPs, which differs from the same construct expressed in Escherichia coli, whereas pentamer aggregates resulted from deletion of the 428–465 region or the C428G mutation. The results have implications both for considering use of single-genotype HPV vaccines, and for design of novel second-generation vaccines. DA - 2006 DB - OpenUCT DP - University of Cape Town J1 - Virus Research LK - https://open.uct.ac.za PB - University of Cape Town PY - 2006 T1 - A deletion and point mutation study of the human papillomavirus type 16 major capsid gene TI - A deletion and point mutation study of the human papillomavirus type 16 major capsid gene UR - http://hdl.handle.net/11427/25729 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/25729
dc.identifier.vancouvercitationVarsani A, Williamson A, Jaffer MA, Rybicki EP. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene. Virus Research. 2006; http://hdl.handle.net/11427/25729.en_ZA
dc.language.isoeng
dc.publisher.departmentDepartment of Molecular and Cell Biologyen_ZA
dc.publisher.facultyFaculty of Scienceen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.sourceVirus Research
dc.source.urihttp://www.sciencedirect.com/science/journal/01681702/130
dc.titleA deletion and point mutation study of the human papillomavirus type 16 major capsid gene
dc.typeJournal Article
uct.type.filetypeText
uct.type.filetypeImage
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Varsani_Papillomavirus_2006.pdf
Size:
965.32 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections